{"id":1131,"date":"2021-04-16T10:22:04","date_gmt":"2021-04-16T10:22:04","guid":{"rendered":"https:\/\/dryamd.eu\/?page_id=2"},"modified":"2022-04-07T15:17:24","modified_gmt":"2022-04-07T15:17:24","slug":"home","status":"publish","type":"page","link":"https:\/\/dryamd.eu\/fr\/","title":{"rendered":"Home"},"content":{"rendered":"<figure class=\"wp-block-video video-fullsize\"><video loop muted poster=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/home_header_placeholder.jpg\" src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/home_header_placeholder.jpg\" playsinline><\/video><\/figure>\n\n\n\n<h1 class=\"h1-inside-video\"><strong>UN REGARD PLUS ATTENTIF SUR <\/strong><br><strong>LA DMLA S\u00c8CHE AVANC\u00c9E OU<\/strong><br><strong>DMLA ATROPHIQUE<\/strong><\/h1>\n\n\n\n<p class=\"mt-5\"><strong>La DMLA s\u00e8che avanc\u00e9e et DMLA atrophique sont les m\u00eames termes utilis\u00e9s pour d\u00e9crire la forme avanc\u00e9e de la d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l&rsquo;\u00e2ge (DMLA s\u00e8che), qui est l&rsquo;une des principales causes de c\u00e9cit\u00e9 dans le monde.<sup>1,2<\/sup><\/strong><\/p>\n\n\n\n<p><strong>Si vous, ou l&rsquo;un de vos proches, \u00eates atteint de DMLA, en particulier de DMLA s\u00e8che avanc\u00e9e ou DMLA atrophique, ce site est con\u00e7u pour vous fournir davantage d&rsquo;informations et de soutien.<\/strong><\/p>\n\n\n\n<br>\n\n\n\n<p>Ce site est uniquement destin\u00e9 \u00e0 des fins d&rsquo;information&nbsp;; il ne doit pas \u00eatre utilis\u00e9 pour diagnostiquer ou traiter un probl\u00e8me de sant\u00e9 ou une maladie. Veuillez consulter votre prestataire de soins de sant\u00e9 pour obtenir des conseils suppl\u00e9mentaires.<\/p>\n\n\n\n<div class=\"wp-container-1 wp-block-buttons my-5\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link\" href=\"https:\/\/dryamd.eu\/fr\/la-dmla\/\">OBTENIR PLUS D&rsquo;INFORMATIONS UTILES<\/a><\/div>\n<\/div>\n\n\n\n<h2>Nous continuerons \u00e0 ajouter du nouveau contenu au fil du temps. N&rsquo;oubliez pas de nous rendre visite r\u00e9guli\u00e8rement pour obtenir de nouvelles informations et des outils de soutien.<\/h2>\n\n\n\n<div class=\"wp-container-5 wp-block-columns row mb-5\">\n<div class=\"wp-container-3 wp-block-column col-12 col-lg-6\">\n<h3><strong>Vivre avec une DMLA s\u00e8che avanc\u00e9e ou une DMLA atrophique<\/strong><\/h3>\n\n\n\n<p>La DMLA s\u00e8che avanc\u00e9e est une maladie oculaire progressive et irr\u00e9versible qui a un impact sur la vie quotidienne.<sup>2<\/sup><\/p>\n\n\n\n<div class=\"wp-container-2 wp-block-buttons\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link\" href=\"https:\/\/dryamd.eu\/fr\/vivre-avec-la-dmla-atrophique\/\">EN SAVOIR PLUS SUR LA VIE AVEC LA DMLA ATROPHIQUE<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-container-4 wp-block-column col-12 col-lg-6\">\n<figure class=\"wp-block-image size-large\"><noscript><img width=\"864\" height=\"596\" src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image1_@2x.jpg\" alt=\"dryAMD.eu Un homme \u00e2g\u00e9 est assis sur un banc.\" class=\"wp-image-808\" srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image1_@2x.jpg 864w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image1_@2x-300x207.jpg 300w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image1_@2x-768x530.jpg 768w\" sizes=\"(max-width: 864px) 100vw, 864px\"><\/noscript><img width=\"864\" height=\"596\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20864%20596%22%3E%3C%2Fsvg%3E\" alt=\"dryAMD.eu Un homme \u00e2g\u00e9 est assis sur un banc.\" class=\"wp-image-808 lazyload\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20864%20596%22%3E%3C%2Fsvg%3E 864w\" sizes=\"(max-width: 864px) 100vw, 864px\" data-srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image1_@2x.jpg 864w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image1_@2x-300x207.jpg 300w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image1_@2x-768x530.jpg 768w\" data-src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image1_@2x.jpg\"><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-container-9 wp-block-columns row mb-5\">\n<div class=\"wp-container-7 wp-block-column col-12 col-lg-6\">\n<h3><strong>Aper\u00e7u avanc\u00e9 de la DMLA s\u00e8che<\/strong><\/h3>\n\n\n\n<p>La DMLA s\u00e8che avanc\u00e9e se caract\u00e9rise par une perte progressive de la vision menant \u00e0 la c\u00e9cit\u00e9.<\/p>\n\n\n\n<div class=\"wp-container-6 wp-block-buttons\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link\" href=\"https:\/\/dryamd.eu\/fr\/vivre-avec-la-dmla-atrophique\/\">EN SAVOIR PLUS SUR LA DMLA S\u00c8CHE AVANC\u00c9E<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-container-8 wp-block-column col-12 col-lg-6\">\n<figure class=\"wp-block-image size-large\"><noscript><img width=\"864\" height=\"596\" src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image2_@2x.jpg\" alt=\"dryAMD.eu DMLA s\u00e8che avanc\u00e9e - Champ de vision limit\u00e9 sur une route.\" class=\"wp-image-809\" srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image2_@2x.jpg 864w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image2_@2x-300x207.jpg 300w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image2_@2x-768x530.jpg 768w\" sizes=\"(max-width: 864px) 100vw, 864px\"><\/noscript><img width=\"864\" height=\"596\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20864%20596%22%3E%3C%2Fsvg%3E\" alt=\"dryAMD.eu DMLA s\u00e8che avanc\u00e9e - Champ de vision limit\u00e9 sur une route.\" class=\"wp-image-809 lazyload\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20864%20596%22%3E%3C%2Fsvg%3E 864w\" sizes=\"(max-width: 864px) 100vw, 864px\" data-srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image2_@2x.jpg 864w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image2_@2x-300x207.jpg 300w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image2_@2x-768x530.jpg 768w\" data-src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image2_@2x.jpg\"><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-container-13 wp-block-columns row mb-5\">\n<div class=\"wp-container-11 wp-block-column col-12 col-lg-6\">\n<h3><strong>\u00c0 propos des maladies maculaires li\u00e9es \u00e0 l&rsquo;\u00e2ge<\/strong><\/h3>\n\n\n\n<p>La r\u00e9tine est une fine couche de tissu situ\u00e9e sur la paroi interne arri\u00e8re de l&rsquo;\u0153il. Diff\u00e9rentes maladies r\u00e9tiniennes telles que la DMLA s\u00e8che avanc\u00e9e peuvent l&rsquo;affecter.<\/p>\n\n\n\n<div class=\"wp-container-10 wp-block-buttons\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link\" href=\"https:\/\/dryamd.eu\/fr\/la-dmla\/\">EN SAVOIR PLUS SUR LES MALADIES MACULAIRES LI\u00c9ES \u00c0 L&rsquo;\u00c2GE<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-container-12 wp-block-column col-12 col-lg-6\">\n<figure class=\"wp-block-image size-large\"><noscript><img width=\"864\" height=\"596\" src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image3_@2x.jpg\" alt=\"dryAMD.eu Maladie de la r\u00e9tine vue en d\u00e9tail.\" class=\"wp-image-810\" srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image3_@2x.jpg 864w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image3_@2x-300x207.jpg 300w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image3_@2x-768x530.jpg 768w\" sizes=\"(max-width: 864px) 100vw, 864px\"><\/noscript><img width=\"864\" height=\"596\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20864%20596%22%3E%3C%2Fsvg%3E\" alt=\"dryAMD.eu Maladie de la r\u00e9tine vue en d\u00e9tail.\" class=\"wp-image-810 lazyload\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20864%20596%22%3E%3C%2Fsvg%3E 864w\" sizes=\"(max-width: 864px) 100vw, 864px\" data-srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image3_@2x.jpg 864w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image3_@2x-300x207.jpg 300w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image3_@2x-768x530.jpg 768w\" data-src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/desk_home_image3_@2x.jpg\"><\/figure>\n<\/div>\n<\/div>\n\n\n\n<h2>Qu&rsquo;est-ce que la DMLA s\u00e8che avanc\u00e9e ou DMLA atrophique?<\/h2>\n\n\n\n<p><strong>Un bref aper\u00e7u<\/strong><br><br>La d\u00e9g\u00e9nerescnce macualire de forme seche li\u00e9e \u00e0 l&rsquo;\u00e2ge est une maladie incurable de la r\u00e9tine qui entra\u00eene une perte de vision progressive et irr\u00e9versible.<sup>2,5<\/sup> Chez les personnes atteintes de DMLA s\u00e8che avanc\u00e9e, les cellules sensibles \u00e0 la lumi\u00e8re, appel\u00e9es photor\u00e9cepteurs, se d\u00e9t\u00e9riorent dans la macula, une partie centrale de la r\u00e9tine responsable de la vision et de la perception des couleurs.<sup>6<\/sup> Cette d\u00e9t\u00e9rioration commence par de petites taches qui se transforment en plaques plus grandes. Au fur et \u00e0 mesure que les cellules de la macula meurent, la personne commence \u00e0 perdre la vue.<sup>6<\/sup> Les personnes atteintes de DMLA s\u00e8che avanc\u00e9e peuvent souffrir d&rsquo;une r\u00e9duction de leur qualit\u00e9 de vie, notamment de plusieurs aspects de la mobilit\u00e9 et de l&rsquo;ind\u00e9pendance.<sup>15,16<\/sup><\/p>\n\n\n\n<div class=\"wp-container-14 wp-block-buttons my-5\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link\" href=\"https:\/\/dryamd.eu\/fr\/la-dmla\/\">EN SAVOIR PLUS SUR LE FONCTIONNEMENT DE LA VISION<\/a><\/div>\n<\/div>\n\n\n\n<h2>Soutien des associations de patients au site dryAMD.eu<\/h2>\n\n\n\n<p class=\"mb-5\">Cette plateforme a \u00e9t\u00e9 d\u00e9velopp\u00e9e en collaboration avec les organisations de patients suivantes afin de s&rsquo;assurer qu&rsquo;elle r\u00e9pond r\u00e9ellement aux besoins des personnes atteintes de d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l&rsquo;\u00e2ge, ainsi qu&rsquo;\u00e0 ceux qui les soignent. <meta charset=\"utf-8\">Nous tenons \u00e0 les remercier pour leur contribution inestimable et leur soutien continu.<\/p>\n\n\n\n<p>Veuillez cliquer sur les liens ci-dessous pour visiter les sites web des organisations de patients.<\/p>\n\n\n\n<br>\n\n\n\n<div class=\"wp-container-16 wp-block-columns row mb-5\">\n<div class=\"wp-container-15 wp-block-column col-12 col-lg-6\"><\/div>\n<\/div>\n\n\n\n<div class=\"wp-container-19 wp-block-columns row mb-5\">\n<div class=\"wp-container-17 wp-block-column col-12 col-lg-6\">\n<p><strong>L&rsquo;association su\u00e9doise de la r\u00e9tinite pigmentaire<\/strong> est une association non gouvernementale, bas\u00e9e sur des ressources volontaires, pour et par les personnes atteintes de r\u00e9tinite pigmentaire (RP) et de maladies r\u00e9tiniennes d\u00e9g\u00e9n\u00e9ratives h\u00e9r\u00e9ditaires apparent\u00e9es.<\/p>\n\n\n\n<p><a href=\"https:\/\/retinanytt.se\/\" target=\"_blank\" rel=\"noreferrer noopener\" title=\"Svenska RP-f\u00f6reningen Website\">Site web de Svenska RP-foreningen<\/a><\/p>\n<\/div>\n\n\n\n<div class=\"wp-container-18 wp-block-column col-12 col-lg-6\">\n<figure class=\"wp-block-image size-large is-resized\"><noscript><img src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_swedisch_retina_@2x.jpg\" alt=\"dryAMD.eu Logo de &quot;l'Association su\u00e9doise de la r\u00e9tinite pigmentaire&quot;.\" class=\"wp-image-811\" width=\"190\" height=\"125\" srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_swedisch_retina_@2x.jpg 760w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_swedisch_retina_@2x-300x197.jpg 300w\" sizes=\"(max-width: 190px) 100vw, 190px\"><\/noscript><img src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20190%20125%22%3E%3C%2Fsvg%3E\" alt=\"dryAMD.eu Logo de &quot;l'Association su\u00e9doise de la r\u00e9tinite pigmentaire&quot;.\" class=\"wp-image-811 lazyload\" width=\"190\" height=\"125\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20190%20125%22%3E%3C%2Fsvg%3E 190w\" sizes=\"(max-width: 190px) 100vw, 190px\" data-srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_swedisch_retina_@2x.jpg 760w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_swedisch_retina_@2x-300x197.jpg 300w\" data-src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_swedisch_retina_@2x.jpg\"><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-container-22 wp-block-columns row mb-5\">\n<div class=\"wp-container-20 wp-block-column col-12 col-lg-6\">\n<p><strong>La vision de la Macular Society<\/strong> est de vaincre la maladie maculaire. Pour ce faire, elle s&rsquo;efforce de trouver un rem\u00e8de gr\u00e2ce \u00e0 une recherche de niveau international, de fournir les meilleurs conseils et le meilleur soutien aux personnes touch\u00e9es par la maladie maculaire, et de mieux faire conna\u00eetre l&rsquo;importance de la sant\u00e9 oculaire.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.macularsociety.org\/\" target=\"_blank\" rel=\"noreferrer noopener\" title=\"Macular Society Website\">Site web de la soci\u00e9t\u00e9 maculaire<\/a><\/p>\n<\/div>\n\n\n\n<div class=\"wp-container-21 wp-block-column col-12 col-lg-6\">\n<figure class=\"wp-block-image size-large is-resized\"><noscript><img src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_macular_society_@2x.jpg\" alt=\"dryAMD.eu Logo der &quot;Macular Society&quot;.\" class=\"wp-image-812\" width=\"190\" height=\"125\" srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_macular_society_@2x.jpg 760w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_macular_society_@2x-300x197.jpg 300w\" sizes=\"(max-width: 190px) 100vw, 190px\"><\/noscript><img src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20190%20125%22%3E%3C%2Fsvg%3E\" alt=\"dryAMD.eu Logo der &quot;Macular Society&quot;.\" class=\"wp-image-812 lazyload\" width=\"190\" height=\"125\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20190%20125%22%3E%3C%2Fsvg%3E 190w\" sizes=\"(max-width: 190px) 100vw, 190px\" data-srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_macular_society_@2x.jpg 760w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_macular_society_@2x-300x197.jpg 300w\" data-src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_macular_society_@2x.jpg\"><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-container-25 wp-block-columns row mb-5\">\n<div class=\"wp-container-23 wp-block-column col-12 col-lg-6\">\n<p><strong>PRO RETINA<\/strong> est une association allemande de patients pour les personnes atteintes de DMLA et de DMIC. Fond\u00e9e en 1977, elle compte aujourd&rsquo;hui plus de 6000 membres qui b\u00e9n\u00e9ficient d&rsquo;un soutien et de conseils pour vivre avec une perte de vision &#8211; pour vivre une vie autod\u00e9termin\u00e9e. PRO RETINA soutient la recherche, sensibilise le public et exerce une influence politique.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.pro-retina.de\/\" target=\"_blank\" rel=\"noreferrer noopener\" title=\"PRO RETINA Deutschland Website\">Site web de PRO RETINA Deutschland<\/a><\/p>\n<\/div>\n\n\n\n<div class=\"wp-container-24 wp-block-column col-12 col-lg-6\">\n<figure class=\"wp-block-image size-large is-resized\"><noscript><img src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_pro_retina_@2x.jpg\" alt=\"dryAMD.eu Logo von der &quot;PRO RETINA&quot;.\" class=\"wp-image-813\" width=\"190\" height=\"125\" srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_pro_retina_@2x.jpg 760w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_pro_retina_@2x-300x197.jpg 300w\" sizes=\"(max-width: 190px) 100vw, 190px\"><\/noscript><img src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20190%20125%22%3E%3C%2Fsvg%3E\" alt=\"dryAMD.eu Logo von der &quot;PRO RETINA&quot;.\" class=\"wp-image-813 lazyload\" width=\"190\" height=\"125\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20viewBox%3D%220%200%20190%20125%22%3E%3C%2Fsvg%3E 190w\" sizes=\"(max-width: 190px) 100vw, 190px\" data-srcset=\"https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_pro_retina_@2x.jpg 760w, https:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_pro_retina_@2x-300x197.jpg 300w\" data-src=\"http:\/\/dryamd.eu\/fr\/wp-content\/uploads\/sites\/4\/2021\/05\/logo_pro_retina_@2x.jpg\"><\/figure>\n<\/div>\n<\/div>\n\n\n\n<p class=\"resources-title\">R\u00e9f\u00e9rences:<\/p>\n\n\n\n<ol><li>Gehrs KM, et al. Ann Med. 2006;38(7):450-471.<\/li><li>Fleckenstein, M. et al. The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology 125, 369\u2013390 (2018).<\/li><li>Sivaprasad S, et al. Ophthalmol Ther. 2019;8:115-124<\/li><li>Kaszubski P, et al. Ophthalmic Res. 2016;55(4):185-193<\/li><li>Boyer, D. S., Schmidt-Erfurth, U., Van Lookeren Campagne, M., Henry, E. C. &amp; Brittain, C. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina 37, 819\u2013835 (2017).<\/li><li>Young, R. W. Pathophysiology of age-related macular degeneration. Surv. Ophthalmol. 31, (1987).<\/li><li>EURETINA. Retinal Diseases in Europe. PDF file. Accessed Apr. 29, 2021.<br>https:\/\/www.euretina.org\/downloads\/EURETINA_Retinal_Diseases.pdf<\/li><li>Age-Related Macular Degeneration: Facts &amp; Figures. Bright Focus Foundation. Accessed Apr. 29, 2021. https:\/\/www.brightfocus.org\/macular\/article\/age-related-macular-facts-figures<\/li><li>Wong WL, et al. Lancet Glob Health. 2014;2:e106-116.<\/li><li>What is Geographic Atrophy? Bright Focus Foundation. Accessed Apr. 29, 2021. https:\/\/www.brightfocus.org\/macular\/article\/what-geographic-atrophy<\/li><li>Ardeljan, D. &amp; Chan, C. C. Aging is not a disease: Distinguishing age-related macular degeneration from aging. Progress in Retinal and Eye Research (2013) doi:10.1016\/j.preteyeres.2013.07.003.<\/li><li>Bear, M., Connors, B. &amp; Paradiso, M. Neuroscience: Exploring the Brain (Third Edition). Library (Lond). (2006) doi:10.1007\/BF02234670.<\/li><li>Bonnel, S., Mohand-Said, S. &amp; Sahel, J. A. The aging of the retina. Exp. Gerontol. (2003) doi:10.1016\/S0531-5565(03)00093-7.<\/li><li>Pennington, K. L. &amp; DeAngelis, M. M. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis. 3, (2016).<\/li><li>Patel PJ, et al. Clin Ophthalmol. 2020;15-28<\/li><\/ol>\n\n\n\n<p><\/p>\n\n\n\n<p>EU-GA-2100003<\/p>\n","protected":false},"excerpt":{"rendered":"<p>UN REGARD PLUS ATTENTIF SUR LA DMLA S\u00c8CHE AVANC\u00c9E OUDMLA ATROPHIQUE La DMLA s\u00e8che avanc\u00e9e et DMLA atrophique sont les m\u00eames termes utilis\u00e9s pour d\u00e9crire la forme avanc\u00e9e de la d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l&rsquo;\u00e2ge (DMLA s\u00e8che), qui est l&rsquo;une des principales causes de c\u00e9cit\u00e9 dans le monde.1,2 Si vous, ou l&rsquo;un de vos proches, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/dryamd.eu\/fr\/wp-json\/wp\/v2\/pages\/1131"}],"collection":[{"href":"https:\/\/dryamd.eu\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dryamd.eu\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dryamd.eu\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dryamd.eu\/fr\/wp-json\/wp\/v2\/comments?post=1131"}],"version-history":[{"count":31,"href":"https:\/\/dryamd.eu\/fr\/wp-json\/wp\/v2\/pages\/1131\/revisions"}],"predecessor-version":[{"id":1542,"href":"https:\/\/dryamd.eu\/fr\/wp-json\/wp\/v2\/pages\/1131\/revisions\/1542"}],"wp:attachment":[{"href":"https:\/\/dryamd.eu\/fr\/wp-json\/wp\/v2\/media?parent=1131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}